ATV-1601

DRUG2 trials

Sponsors

Atavistik Bio, Inc

Conditions

Advanced Solid TumorsBreast CancerBreast CarcinomaBreast DiseasesBreast NeoplasmsCervical CancersCervical CarcinomaCervical Neoplasms

Phase 1

A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations

Active, not recruitingNCT07038369

Atavistik Bio, IncAdvanced Solid Tumors, Breast Cancer, Breast Carcinoma +24

Start: 2025-07-29End: 2029-01-31Target: 134Updated: 2026-08-07

Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)

RecruitingNCT07601425

Atavistik Bio, IncHereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease

Start: 2026-07-27End: 2030-03-01Target: 100Updated: 2026-09-01